IMRT Plus PD-1 Blockade and Lenvatinib for HCC With PVTT (Vp3) Before Liver Transplantation
Learn more about:
Related Clinical Trial
PADUA PREDICTION SCORE in Cirrhotic Patients
Freiburg TIPS Registry
Proton Beam Radiotherapy Followed by Tecentriq and Avastin for Primary Liver Cancer With Vp2-4 Portal Vein Invasion
A Practical Nomogram Based on Systemic Inflammatory Markers for Predicting Portal Vein Thrombosis in Patients With Liver Cirrhosis
Risk Factors for Recurrence of Thrombosis or Thrombotic Extension, in the Event of Acute Non-cirrhotic Portal Vein Thrombosis Secondary to a Local Cause.
IMRT Plus PD-1 Blockade and Lenvatinib for HCC With PVTT (Vp3) Before Liver Transplantation
HAIC Combine With Lenvatinib and Camrelizumab for Advanced HCC With PVTT
Living Donor Liver Transplantation to Patients With Portal Vein Thrombosis
Global Coagulation Assessment in Portal Vein Thrombosis and Budd-Chiari Syndrome
Analysis of Neutrophil Extracellular Traps in Hypercoagulability and Portal Vein Thrombosis in Liver Cirrhosis Patients
Safety of Anticoagulant Therapy After Variceal Band Ligation
Efficacy and Safety of Dabigatran in Patients With Cirrhosis and Portal Vein Thrombosis
Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism
Vienna Vascular Liver Disease Study
EASYX-1 : A Multicenter Study on Safety and Efficacy of Easyx Liquid Embolization Agent Used in Five Separate Indications
Efficacy of Statin Association With Standard Treatment in Prevention of Recurrent Hemorrhage in Patient With Cirrhosis and Variceal Bleeding
Sorafenib Plus Hepatic Arterial Infusion Versus Sorafenib for HCC With Major Portal Vein Tumor Thrombosis
Treatment of Splanchnic Vein Thrombosis With Rivaroxaban. A Pilot, Prospective Cohort Study
Chances in Portal System Flow After Two Bariatric Procedures
Prognostic Value Related to the Presence of Thrombosis or Portal Vein Invasion in Patients With Hepatocellular Carcinoma Submitted to Surgery
SBRT+TACE+Sorafenib Vs Sorafenib in the Treatment of uHCC With PVTT
Neo-TACE-HAIC for PVTT-HCC
Efficacy and Safety of Acenocoumarol for Treatment of Nontumor Portal Vein Thrombosis in Cirrhosis of Liver
Anticoagulation Post Laparoscopic Splenectomy
TIPS for Variceal Rebleeding in Cirrhotic Patients With Occlusive Portal Vein Thrombosis and CTPV
Role of EUS Guided FNA of Portal Vein Thrombus in the Diagnosis and Staging of Hepatocellular Carcinoma
The Effect of Anticoagulation After Endoscopic Therapy in Cirrhotic Patients With Portal Vein Thrombosis
The Effect of Anticoagulation in Cirrhotic Patients With Portal Vein Thrombosis:A Multicenter RCT
Anticoagulation for Non-occlusive Portal Vein Thrombosis in Patients With Liver Cirrhosis
Transjugular Intrahepatic Portosystemic Shunt (TIPS) for Prevention of Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis
Incidence of Venous Thromboembolic Disease and Portal Vein Thrombosis After Hepatectomy. A Cohort Study.
Efficacy and Safety of Rivaroxaban in the Management of Acute Non-neoplastic PVT Compensated Cirrhosis
Preventing de Novo Portal Vein Thrombosis With Antithrombin-III in Patients With Cirrhosis
Efficacy and Safety of Anticoagulant Therapy in Portal Vein Thrombosis
Placebo-controlled Study of NPB-06 in Patients With Portal Vein Thrombosis
Prevalence and Predictive Factors of Portal Vein Thrombosis in Patients With Cirrhosis
TheraSpheres Treatment for Unresectable Hepatocarcinoma and Portal Vein Thrombosis
Efficacy and Safety of Rivaroxaban in Acute Non-neoplastic Portal Vein Thrombosis in HCV
Xarelto Versus no Treatment for the Prevention of Recurrent Thrombosis in Patients With Chronic Portal Vein Thrombosis.
Clinical Course of Cirrhotic Patients With Portal Vein Thrombosis Treated With TIPS
TIPS vs Endoscopic Therapy for Variceal Rebleeding in Cirrhotic Patients With Portal Vein Thrombosis
The Effect of Rifaximin on Portal Vein Thrombosis